RESPIRATORY TRACT INFECTIONS
Clinical trials for RESPIRATORY TRACT INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY TRACT INFECTIONS trials appear
Sign up with your email to follow new studies for RESPIRATORY TRACT INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New test aims to stop unnecessary antibiotics for respiratory infections
Diagnosis Recruiting nowThis study tests a new diagnostic tool that helps doctors quickly tell whether a respiratory infection is caused by bacteria or a virus. By using this test early, doctors hope to make better treatment decisions, reduce unnecessary antibiotics, and lower healthcare costs. The stud…
Matched conditions: RESPIRATORY TRACT INFECTIONS
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Diagnosis
Last updated May 01, 2026 16:44 UTC
-
Can new pulse oximeters save more babies from pneumonia?
Knowledge-focused Recruiting nowThis study tests three new pulse oximeters (devices that measure oxygen levels) in 1,200 children under 2 years old with pneumonia in Cape Town, South Africa. The goal is to see if these devices help healthcare workers correctly identify low oxygen levels and refer children for p…
Matched conditions: RESPIRATORY TRACT INFECTIONS
Phase: NA • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated May 01, 2026 16:01 UTC
-
Scientists probe Nose's 'Lost' immune cells in aging
Knowledge-focused Recruiting nowThis study aims to understand why older adults, especially those who are frail, lose important immune cells (T cells) from their nasal passages, making them more prone to lung infections. Researchers will compare nasal and blood samples from 170 healthy young adults, healthy olde…
Matched conditions: RESPIRATORY TRACT INFECTIONS
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC
-
New antibiotic candidate JKN2501 begins first human safety tests
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug called JKN2501 in 66 healthy adults to see if it is safe and how the body processes it. The drug is being developed to fight bacterial infections like urinary tract and lung infections. Participants will receive either the drug or a pl…
Matched conditions: RESPIRATORY TRACT INFECTIONS
Phase: PHASE1 • Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:48 UTC